ALEXANDRA ACKERMAN: Open Payments
NPI 1669100418 · NEWNAN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$564 in 28 payments from 14 companies in 2025. Trend: 2023 $112 · 2024 $0 · 2025 $564
Food & beverage: $564
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $142 |
| PFIZER INC. | 3 | $58 |
| Sumitomo Pharma America, Inc. | 2 | $46 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
| Janssen Pharmaceuticals, Inc | 2 | $38 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| SANOFI-AVENTIS U.S. LLC | 2 | $37 |
| Axsome Therapeutics, Inc. | 1 | $33 |
| ABBVIE INC. | 2 | $30 |
| Edwards Lifesciences Corporation | 1 | $29 |
Products named: AIRSUPRA, NURTEC ODT, GEMTESA, JARDIANCE, SPRAVATO, XIFAXAN, TZIELD, Symbravo.
Industry payments across GA — which companies pay providers there.
